Pulmonary hypertension trials recruiting in Massachusetts

All Pulmonary hypertension trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
  NCT07333183 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Massachusetts: Boston
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
  NCT06129240 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · Massachusetts: Boston
• Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
  NCT05937854 · Phase: Phase 2 · Ages: 35 Years to 89 Years · Sex: All (male and female) · Massachusetts: Boston
• Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
  NCT06911632 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
  NCT04555161 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston